Specimen Collection Media Proven to Inactivate Sars CoV-2 by Rutgers University also Most Effectively Stabilizes SARS-CoV-2 RNA Fragments
Lowering the Limit of Detection (LoD) of SARS-CoV-2 RNA in COVID-19 tests is critical to better identification of COVID-19 patients including those with low viral loads. Effective control of disease spread requires safer handling of specimens and tests with higher sensitivity to identify both symptomatic and asymptomatic patients.
The non-toxic and non-flammable VTM that CPT Medical utilizes in their specimen collection kits is safer for laboratory staff conducting RNA extraction due to its properties that inactivate the Sars CoV-2 virus – proven in a study conducted by Rutgers University. It also maintains higher stabilization of specimens at room temperature for more accurate results.
With chemistry that has been shown to maintain higher freeze-thaw integrity than most transport media, this ITM also allows for more accurate Next Generation Sequencing to monitor for new variants of the COVID-19 virus, as the freeze-thaw method is often conducted during genomic sequencing. More information on this breakthrough ITM is to come.